PCSK9 gene
Evidence from:
primary |
all sources
Related entities (7)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| PCSK9 | associated_with | cardiovascular disease | — | 1 |
| PCSK9 | associated_with | LDL cholesterol | 1e-13 | 1 |
| PCSK9 | regulates | LDL cholesterol | — | 1 |
| PCSK9 | associated_with | lipid levels | — | 1 |
| PCSK9 | associated_with | lipid metabolism | — | 1 |
| PCSK9 | associated_with | risk factor | — | 1 |
| PCSK9 | expressed_in | tibial nerve | 1e-27 | 1 |
Mentioned in (10)
Papers in which this entity is mentioned.
- Yield of genetic association signals from genomes, exomes and imputation in the UK Biobank. (2024)
- Epsin Nanotherapy Regulates Cholesterol Transport to Fortify Atheroma Regression. (2023)
- Biobank-scale methods and projections for sparse polygenic prediction from machine learning. (2023)
- Genetics of substance use disorders in the era of big data. (2021)
- The mutational constraint spectrum quantified from variation in 141,456 humans. (2020)
- The mutational constraint spectrum quantified from variation in 141,456 humans (2019)
- Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. (2018)
- Translating genome-wide association findings into new therapeutics for psychiatry. (2016)
- Clinical exome performance for reporting secondary genetic findings. (2015)
- Finding the missing heritability of complex diseases. (2009)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| pcsk9 | gene | 10 | 25 |